Education
About Us
Working with TipRanks
Follow Us
InnoCan Pharma (INNPF)
OTHER OTC:INNPF
INNPF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.09 - $0.24
Previous CloseN/A
Volume45.00K
Average Volume (3M)350.00
Market Cap
$37.69M
Enterprise ValueN/A
Total Cash (Recent Filing)$5.06M
Total Debt (Recent Filing)$1.00K
Price to Earnings (P/E)―
Beta-0.19
Next Earnings
Sep 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding292,420,170
10 Day Avg. Volume50
30 Day Avg. Volume350
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)8.05
Price to Sales (P/S)0.00
P/FCF Ratio-16.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
InnoCan Pharma News
PremiumCompany Announcements
Innocan Pharma Advances Non-Opioid Pain Management with Synthetic CBD
PremiumCompany Announcements
Innocan Pharma Reports Strong Q1 2025 Results and Advances CBD Technology
PremiumCompany Announcements
Innocan Pharma Secures First Mexican Patent for Cannabis-Based Pain Relief
PremiumCompany Announcements
Innocan Pharma Closes Private Placement to Bolster Operations
PremiumCompany Announcements
Innocan Pharma Expands IP in Asia and Announces Private PlacementPremiumCompany Announcements
Innocan Pharma’s 2024 Revenue Surges Amid Strategic Growth
PremiumCompany Announcements
Innocan Pharma Announces $1 Million Debenture Offering to Tamar Innovest
PremiumCompany Announcements
Innocan Pharma Secures Indian Patent for Liposomal CBD InjectionOptions Prices
Currently, No data available
---
Ownership Overview
INNPF FAQ
What was InnoCan Pharma’s price range in the past 12 months?
InnoCan Pharma lowest stock price was $0.09 and its highest was $0.24 in the past 12 months.
What is InnoCan Pharma’s market cap?
InnoCan Pharma’s market cap is $37.69M.
When is InnoCan Pharma’s upcoming earnings report date?
InnoCan Pharma’s upcoming earnings report date is Sep 01, 2025 which is in 76 days.
How were InnoCan Pharma’s earnings last quarter?
Currently, no data Available
Is InnoCan Pharma overvalued?
According to Wall Street analysts InnoCan Pharma’s price is currently Overvalued.
Does InnoCan Pharma pay dividends?
InnoCan Pharma does not currently pay dividends.
What is InnoCan Pharma’s EPS estimate?
InnoCan Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InnoCan Pharma have?
InnoCan Pharma has 292,420,170 shares outstanding.
What happened to InnoCan Pharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InnoCan Pharma?
Currently, no hedge funds are holding shares in INNPF
Company Description
InnoCan Pharma
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.
Technical Analysis
Mountain Valley MD
―
Medicure
―
Medexus Pharmaceuticals Inc
―
Revive Therapeutics
―
BioNxt Solutions
―